189 related articles for article (PubMed ID: 1313957)
1. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
Arslanian S; Ohki Y; Becker DJ; Drash AL
Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
3. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
Trümper BG; Reschke K; Molling J
Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
[TBL] [Abstract][Full Text] [Related]
4. The dawn phenomenon does not occur in normal elderly subjects.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
[TBL] [Abstract][Full Text] [Related]
5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of a dawn phenomenon in normal adolescents.
Arslanian S; Ohki Y; Becker DJ; Drash AL
Horm Res; 1990; 34(1):27-32. PubMed ID: 1963621
[TBL] [Abstract][Full Text] [Related]
7. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
8. Failure to detect the "dawn phenomenon" in nondiabetic subjects with markedly different patterns of nocturnal growth hormone secretion.
Mauras N; Rogol AD; Clarke WL
J Clin Endocrinol Metab; 1986 May; 62(5):975-9. PubMed ID: 3514653
[TBL] [Abstract][Full Text] [Related]
9. Responses to continuous and intermittent exercise in healthy and insulin-dependent diabetic children.
Sills IN; Cerny FJ
Med Sci Sports Exerc; 1983; 15(6):450-4. PubMed ID: 6361439
[TBL] [Abstract][Full Text] [Related]
10. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
Bolli GB; Perriello G
Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
[TBL] [Abstract][Full Text] [Related]
11. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
12. Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects.
Jauch-Chara K; Hallschmid M; Schmid SM; Oltmanns KM; Peters A; Born J; Schultes B
Diabet Med; 2007 Jun; 24(6):684-7. PubMed ID: 17381498
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
[TBL] [Abstract][Full Text] [Related]
14. Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.
Beaufrère B; Beylot M; Metz C; Ruitton A; François R; Riou JP; Mornex R
Diabetologia; 1988 Aug; 31(8):607-11. PubMed ID: 3065115
[TBL] [Abstract][Full Text] [Related]
15. [Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon].
Consoli A; Capani F; Vitacolonna E; Sensi S
Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1685-9. PubMed ID: 6395872
[TBL] [Abstract][Full Text] [Related]
16. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
[TBL] [Abstract][Full Text] [Related]
18. Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.
Boyle PJ; Avogaro A; Smith L; Shah SD; Cryer PE; Santiago JV
Diabetologia; 1992 Apr; 35(4):372-9. PubMed ID: 1516766
[TBL] [Abstract][Full Text] [Related]
19. The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus.
Perriello G; De Feo P; Torlone E; Calcinaro F; Ventura MM; Basta G; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
N Engl J Med; 1988 Nov; 319(19):1233-9. PubMed ID: 3054544
[TBL] [Abstract][Full Text] [Related]
20. Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients.
Kerner W; Navascués I; Torres AA; Pfeiffer EF
Metabolism; 1984 May; 33(5):458-64. PubMed ID: 6371444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
